Markets in Human Reproductive Medicine

    Published: May 1, 2005 | Price: $3,500.00 – $7,000.00

    This study provides a comprehensive analysis of available and emerging reproductive products and technologies related to contraception and infertility treatments. The goal of this study is to provide a comprehensive range of information from detailed product analyses through industry trends, and to quantify and qualify the market for hormonal contraceptives, infertility pharmaceuticals, and for assisted reproductive technologies. The report forecasts the following markets through 2008: The world market oral contraceptives The world market hormonal contraceptive devices The world market infertility...
    Direct-to-Consumer Testing Market

    Published: January 14, 2019 | Price: $4,500.00 – $9,000.00

    Direct-to-Consumer Testing Market With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare. The global DTC testing market is divided into two distinct areas of DTC testing: Routine clinical laboratory testing Medical genetic...
    Cell-Free DNA (cfDNA): Market Size and Share Analysis (Consumables, Systems, Services)

    Published: April 12, 2017 | Price: $2,800.00 – $5,600.00

     Cell-Free DNA (cfDNA) Markets details the market opportunity for cfDNA analysis instruments, consumables, kits, and related software. The report provides complete market information, including current market estimates and forecasts to 2021, as well as: Growth Rate for cfDNA Market, 2016-2021 cfDNA Clinical Diagnostics Market, 2016-2021 cfDNA Clinical Diagnostics Market Growth Rate, 2016-2021 cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW) cfDNA Instruments and Consumables Revenues by Product Type, 2016 (Consumables, Systems, Services) Market Share by Company of...
    Point of Care Diagnostics for Emerging Infectious Disease Threats (Dengue Fever, HIV, HPV, STDs, Chagas, TB, and Other IDs): Market Analysis and Technical Considerations

    Published: October 1, 2011 | Price: $150.00 – $300.00

    The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...
    Cell-Based Diagnostics – Technology, Applications, and Markets, 2nd Edition

    Published: November 1, 2007 | Price: $1,995.00 – $3,990.00

    No longer is cell-based diagnostics simply a histological study of biopsied and surgical tissues. Combinations of tests and technologies are coming together to create a new map of cell diagnostics. Image cytometry, microfluidics, microarrays, and biosensors, special immunohistochemical and in situ hybridization probes are creating new approaches to cell and tissue observation, diagnostics and pharmacogenomics. This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood,...
    Medical Imaging Markets, Volume IV – Contrast Agents

    Published: February 1, 2007 | Price: $1,995.00 – $5,990.00

    Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...
    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    Published: April 1, 2006 | Price: $3,900.00 – $7,800.00

    This completely updated edition of Kalorama’s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including: Point-of-Care Clinical Chemistry Immunoassays Molecular Assays Hematology Coagulation Microbiology and Virology Blood Banking Histology and Cytology Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Projections are made through 2010. This new 1,000-page...
    Sample Preparation and Library Preparation for DNA Sequencers (Results of The Kalorama Survey of Labs)

    Published: January 1, 2011 | Price: $150.00 – $300.00

    Sample preparation and library preparation are important steps in the DNA sequencing process with specialized products and companies. Based on a survey of labs worldwide conducted by Kalorama's biotech analyst Justin Saeks, this report provides detailed information on the current state of DNA sequencing sample preparation and library preparation for next-generation systems, as well as sample preparation, cycle sequencing and sequencing reaction cleanup with capillary systems. The report's perspective is demand-side, focusing on what labs are doing today. The information...
    Smoking Cessation: World Markets

    Published: November 1, 2008 | Price: $995.00 – $3,000.00

    Smoking cessation is among the most dynamic pharmaceutical markets, and one that is expected to grow despite economic conditions. More than 5 million deaths are attributed to nicotine each year. This has encouraged public health entities to pursue smoking cessation, and has driven development of smoking cessation products, both prescription and over the counter. The arrival of Chantix/Champix and its unique marketing strategy and a robust pipeline bodes well for growth in this pharmaceutical segment. This report, Smoking Cessation: World...
    Growth Factors: Indications, Products, and Markets

    Published: October 1, 2003 | Price: $2,625.00 – $5,250.00

    Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or, in some cases, blocks the ability of cells to divide and multiply. The nature and mode of action of these substances have made them of great interest in various therapeutic areas for which efficacy and specificity must go hand in hand. This report analyzes the world markets for growth factors,...
    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 18th Edition (2025-2030)

    Published: September 9, 2025 | Price: $12,000.00 – $18,500.00

    The Online + Download (unlimited users) license includes access to six issues of Kalorama’s In Vitro Diagnostic Business Outlook, as well as a March 2026 update to The Worldwide Market for In Vitro Diagnostic (IVD) Tests. Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 18th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2025 to 2030, and essential insights needed to...
    Markets for Blood Testing and Typing

    Published: June 9, 2017 | Price: $3,196.00 – $6,392.00

    The Market for Blood Testing and TypingThis Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were...
    The Market for Mobile Medical Apps

    Published: June 6, 2012 | Price: $995.00 – $1,990.00

    Use of mobile devices in the healthcare field has taken off in a way not surprising given the fast pace of healthcare work.  Innovative companies have been well ahead of this trend and launched applications that are seeing revenues.  Kalorama Information has studied the market over the past two years and found a growing market with room for new entrants.  This Kalorama Information report, The Worldwide Market for Mobile Medical Apps detailsthe smartphone and other mobile applications or “apps” that are...
    Vaccines 2014: World Market Analysis with Forecasts to 2020, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)

    Published: April 21, 2014 | Price: $995.00 – $1,990.00

    Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments The global market for human vaccines experienced strong growth through 2013 with the introduction of new vaccines. These new products and other trends are well-covered in Vaccines: The World Market. The Kalorama information report examines the global market for vaccines, covering specifically commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable. Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission....
    The Market and Future Potential for Molecular Point of Care

    Published: March 11, 2020 | Price: $4,000.00 – $8,000.00

    THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/   This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...